Rising obesity and chronic disease are making ultrasound exams more complex, leading to higher rates of inconclusive results and creating demand for advanced imaging technologies that provide deeper penetration, intelligent clinician support and diagnostic consistency. At the same time, widespread sonographer pain and workforce shortages highlight the importance of ergonomic design. The R20 was designed to meet these challenges head-on, combining imaging precision, Artificial Intelligence (AI) and ergonomics in a single system.

Built for exceptional imaging performance, the R20 is powered by Samsung’s Advanced Imaging Engine: integrating cutting-edge hardware with sophisticated software beamforming to achieve remarkable image clarity and diagnostic accuracy. R20 offers more than a dozen AI-powered tools¹ for real-time exam guidance, diagnostic assistance, workflow automation and automated measurements to help clinicians improve accuracy, save time and scan with greater confidence in complex cases. Complementing its clinical performance, the R20 achieved independent validation as a leader in ergonomic innovation, meeting 100% of recognized ergonomic guidelines and recommendations² to promote clinician comfort and healthy scanning.

“The R20 embodies our mission to elevate diagnostic imaging through purposeful innovation,” said Tracy Bury, Chief Commercial Officer of Samsung Healthcare in the USA and Vice President of Global Growth Initiatives. “Driven by close collaboration with clinicians, the R20’s technologies are designed as practical tools that make a real difference in how clinicians work and patients are cared for. With the R20, we’re moving from a fast follower to a true technology leader, driving innovation at a pace that’s reshaping ultrasound.”

The Samsung R20 will be unveiled in the U.S. for the first time at the Radiological Society of North America (RSNA) 2025 Annual Meeting on Sunday, November 30, 2025 from 11:00–11:15 a.m. at the Samsung booth #6122 in North Hall B.

Attendees are invited to experience the R20 firsthand and explore how Samsung is redefining ultrasound performance through innovation in imaging, AI and ergonomics. For more information about the Samsung R20, visit: https://usa.samsunghealthcare.com/ultrasound/general-imaging/r20.

1. Data on file. Product features and availability may vary by region due to local regulatory requirements. ︎
2. Whitepaper. Sound Ergonomics. Samsung R20 Ergonomic Evaluation. 2025 ︎

Samsung Medison is garnering attention from the global medical community with its ultrasound diagnostic solutions across the women’s life stage from fetal stage to menopause.

At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, Mexico on September 14, Samsung Medison will showcase its comprehensive women’s health solution under the theme “From Challenges to Solutions: Experience the Innovation.”

From Fetal Stage to Menopause Ultrasound Solution Demonstration Tailored to Women’s Life Stages

The highlight of upgraded HERA Z20, to be unveiled at ISUOG, features diagnostics tailored to every life stage of women. It supports healthcare professionals in managing women’s health comprehensively with a single equipment, enabling dedicated management of women’s health across all stages, from adolescent gynecological conditions and fertility to maternity and aging.

Newly added PelvicAssist and three types of reporting features propose diagnostic support innovation for the women and healthcare professionals whom have difficulties due to the gynecological conditions. PelvicAssist automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing the 3D image.

Due to the complexity of anatomical structures, considerable time is required to precisely assess and report lesion location, size, shape and degree of invasion. In response, Samsung Medison has unveiled tailored diagnostic reporting solution based on standardized clinical guidelines.

Fibroid 2D, which simplifies the reporting procedure for uterine fibroid by applying The International Federation of Gynecology and Obstetrics (FIGO) guideline. IDEA and IETA highly enhanced diagnostic workflow efficiency by supporting scan procedures and reporting based on guidelines for endometriosis and endometrial tumor evaluation, respectively.

The ultra-compact probe Mini ER7, developed to minimize patient discomfort during gynecological examinations by offering 63% smaller head compared to conventional probes, it is expected to significantly reduce the burden for adolescent and elderly patients.

Ultrasound Solutions for High-risk Pregnancy Care and Enhanced Clinical Efficiency

With maternal age on the rise, high-risk pregnancies are becoming common. In response to this social challenge, Samsung Medison has integrated Ophthalmic Artery feature to detect systemic vasoconstriction in early stages — a key factor of pre-eclampsia.

As the Ophthalmic Artery branches directly from the internal carotid artery, it allows for indirect monitoring of cerebral blood flow, which is difficult to access, enabling the early detection of potential cardiovascular disease. The expanded HeartAssist further supports maternal health by real-time monitoring of cardiovascular conditions during pregnancy.

Healthcare professional’s work efficiency is at the center of Samsung Medison’s innovation. Live ViewAssist automatically extracts up to 39 ultrasound cross-sectional images, provides automated annotations and measurement results for key parameters throughout the pregnancy cycle, and reduce diagnostic time.

The integrated QualityCheck feature automatically evaluates the quality of extracted images during fetal diagnosis, supporting consistency of diagnostic accuracy.

Jihyun Kim, Head of the CX group at Samsung Medison said: “The Upgraded HERA 20 is more than just an equipment enhancement but it’s a total solution designed to support women’s health across all life stages. By combining AI technology with the healthcare professional’s clinical experience, we aim to enhance diagnostic accuracy and reduce burdens, ultimately driving meaningful change in the healthcare field.”

Samsung Electronics Health and Medical Equipment Business and Samsung Medison participated in the 2024 Radiological Society of North America (RSNA) conference in Chicago, United States, from December 1st to 5th (local time) and unveiling an even more diverse product lineup.

To strengthen its competitiveness across medical specialties, after the launch of a new OB & GYN ultrasound diagnostic system, HERA Z20, Samsung proposed ‘pediatric integrated solution’ encompassing the entire range of its medical diagnostic devices through this RSNA.

In the ‘Ultrasound Zone,’ a dedicated probe for the pediatric cardiac diagnosis ‘TA2-9’ was unveiled for the first time at this exhibition. The TA2-9 with 42% smaller head than adult echocardiography probe aids in more accurate diagnosis for congenital heart disease or functional and structural abnormalities of heart through the oral route. Also on display was ‘L3-22’, a dedicated neonatal probe featuring a smaller head compared to an adult version offering a wide frequency range which enables pediatric body scan with a single device without the need to switch probes.

All US Food and Drug Administration (FDA) 510(k) cleared products of Samsung digital X-ray have ‘low dose’ capability making it more appropriate for diagnosis of children and adolescents where safety is particularly prioritized. Samsung’s proprietary S-Vue imaging engine reduces radiation exposure by up to 50% compared to systems without this technology.

At this exhibition, Samsung launched a new ‘floor-mounted’ digital X-ray, GF 85. The new digital X-ray, GF 85 launched by Samsung is relatively affordable compared to ceiling-mounted type and cost-effective with the ability to be installed in a small space without ceiling construction. Moreover, it provides clear image quality even with low dose and is equipped with advanced AI diagnostic assistance feature, fully inheriting all the advantages of previous digital X-ray models.

NeuroLogica Corp, a subsidiary of Samsung Electronics, includes the OmniTom Elite mobile computed tomography (CT) in its portfolio, useful for imaging pediatric patients and at point-of-care, facilitating rapid clinical decision making and reducing transport related risks. Mobile CT is already recognized for its utility, with 8 out of the top 10 U.S. pediatric hospitals (as ranked by U.S. News for 2024-2025) utilizing the technology.

NeuroLogica’s OmniTom Elite with photon counting detector (PCD) technology showcased this year’s at RSNA delivers ultra high-resolution CT imaging at the point-of-care using FDA 510(k) cleared PCD technology, surpassing conventional CT methods that rely on energy integrating detectors. By utilizing photon counting detectors to measure the energy of each individual photon, this cutting-edge technology enhances contrast differentiation and virtual monoenergetic imaging, empowering radiologists with greater confidence in diagnosing patients.

Samsung provides opportunity to gain clinical application tips of Samsung medical devices and engage in Q&A with the global experts through Lunch & Learn session. In this session, a global breast imaging expert, Dr. Nina Vincoff shared a screening program using Samsung breast ultrasound solution and the latest insights on the FDA’s mandate for breast density information provision and implementation of additional imaging examination recommendation for dense breast (effective on September 10, 2024).

Dr. Farhad Farzanegan in Kasier Permanente South Sacramento health system U.S. presented a case study on hospital workflow improvement based on the result of CT intervention procedure using Samsung mobile full-body CT, BodyTom.

In the booth, Dr. Jon Jacobson, a musculoskeletal radiology expert, conducted live scan using a premium ultrasound diagnostic device, RS85 Prestige introducing clearer image quality and more sophisticated AI diagnostic assistance feature.

The leader of the Samsung Medison AI&Informatics group, Vijay, said “I discovered a greater potential through high praises from medical professors around the world who visited the site” and “Moving forward, we aim to further enhance our AI diagnostic support features tailored to specialized medical fields, solidify our technological leadership in radiology and obstetrics, and expand our competitiveness across all medical disciplines to pioneer new markets.”

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, participates the 34^th annual academic conference of ISUOG World Congress 2024 (International Society of Ultrasound in Obstetrics & Gynecology) held in Budapest, Hungary from 15 to 18 September.

Samsung Medison showcases HERA Z20, a new premium ultrasound system for OB&GYN, in ISUOG regarded as the most important academic conference in the world in the field of OB&GYN ultrasound.

HERA Z20 further enhanced the cutting edge AI diagnostic assistance features to improve health of women and fetuses. The Live ViewAssist provides a real-time diagnosis location, is newly integrated to HERA Z20. The Live ViewAssist reduces time required for measurement and increases accuracy by automatically classifying cross sections and providing measurement results for entire quarter of OB&GYN.

Live Q-scan and A-Focus features have been newly added to HERA Z20 to provide a more uniform image and sharper image quality. The Live Q-scan reduces noises that appear during the ultrasound examination in real-time, and A-Focus provides clearer images in every scanning depth. Crystal Architecture, Samsung Healthcare proprietary ultrasound imaging technology, also uses the upgraded second generation engine to increase clarity of image.

HERA Z20 enhances user convenience through My HERA going beyond the AI diagnostic assist feature. My HERA as a feature enabling user to build personalized ultrasound system by setting the diagnostic setting values for each user type in advance, can be customized depending on user preference.

Additionally, the EzStructure and EzFlow features provide convenient, optimal imaging settings for the anatomy to be examined with a single touch of a button. The main monitor and touch panel have freely adjustable angles and are ergonomically tailored for user convenience.

Samsung Medison plans to conduct a live scan of the HERA Z20 onsite to showcase the real-time AI diagnostic assist and reporting features that are faster and stronger than before.

In ISUOG, Samsung Medison also introduces theSUITE website for the first time along with HERA Z20 where educational contents of Samsung ultrasound system are complied. The new website membership registration event will be held to celebrate theSUITE launch in ISUOG. Samsung Medison will utilize theSUITE to improve access to the information of each product feature for domestic and overseas medical professionals and secure global bidding competitiveness.

Meanwhile, Samsung Medison pursues the realization of eco-friendly values based on IT technology of Samsung from the product development stage by minimizing energy consumption through analysis of customer’s product usage pattern.

HERA Z20 has reduced the product volume minimizing the number of components by incorporating circuit integration technology mainly utilized for mobile devices, etc. In addition, the packaging and cushioning materials are the replaced with 100% recycled paper by optimizing the packing design to withstand heavy load on paper, and eco-friendly recycled plastic material is utilized for the system body.

Samsung Medison designated part of exhibition hall as ‘eco-friendly zone’ and shares own energy policy at the booth that built using environmental friendly materials.

Kyutae Yoo, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison said “We are committed to doing our best to further increase global market share through launch of a new premium ultrasound system for OB&GYN, new educational website and synergy with Sonio which is equipped with exceptional AI reporting software,” and “We will leap forward as a global leader in the medical equipment industry by improving product performance and sustainability through technology innovation.”

Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT solutions and AI assistant features for obstetrics and gynecology ultrasound that assist medical professionals in the evaluation and documentation of ultrasound exams.

Sonio Detect, an FDA 510(k) cleared AI assistant, leverages deep learning networks to ensure higher image quality in real time and improve quality of care through greater clinical accuracy.

Following the completion of the transaction, Sonio will remain an independent company headquartered in France and will continue its commercial growth independently while its products and services will remain compatible with all ultrasound device makers.

Together with Sonio’s world-class AI expertise, Samsung Medison’s leading-edge ultrasound systems will help bring to market breakthrough AI-enhanced workflows and accelerate innovation in patient outcomes and quality of prenatal care.

“We have great respect and admiration for what the Sonio team has built in the area of maternal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” said Yong Kwan Kim, Samsung Medison CEO. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”

“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” said Cécile Brosset, Sonio CEO. “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.”

The closing of the transaction is subject to applicable regulatory approvals, and notably the approval of the French Ministry of the Economy and Finance.

About Samsung Medison
Samsung Medison is a leading global medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being to people’s lives, the company is committed to creating a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating the world’s best IT, image processing, semiconductor and communication technologies into medical devices. For more information, please visit https://www.samsungmedison.com/

About Sonio
Sonio’s AI-enhanced software empowers prenatal sonographers and ultrasound readers and assists them in performing prenatal examinations that meet the highest quality standards, while ensuring the completeness of each examination, streamlining their workflow and increasing the accuracy of prenatal diagnoses. Sonio’s software is the product of more than five years of research and collaboration between leading experts in the areas of maternal-fetal medicine and AI. Sonio’s investors include Elaia Partners, Bpifrance’s French Tech Seed fund, OneRagtime, Cross Border Impact Ventures and EIC Fund (European Innovation Council). To learn more about Sonio, visit our website https://sonio.ai/

▲ The high-tech, yet highly mobile OmniTom Elite with Photon Counting Detector (PCD) CT scanner is designed to offer advanced imaging at the point-of-care.

NeuroLogica Corp., a subsidiary of Samsung Electronics and a pioneer in premium diagnostic imaging solutions, will showcase its latest offerings in mobile computed tomography (CT) and feature the OmniTom^® Elite Photon Counting mobile CT scanner at the Radiological Society of North America (RSNA) Annual Meeting in Chicago from November 26 to November 30.

The clinical launch of the OmniTom Elite Photon Counting mobile CT scanner, a single-source photon counting computed tomography scanner utilizing NeuroLogica’s proprietary detector technology (PCD), will be featured at this year’s meeting. Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field, capturing the X-ray photons directly at the detector and converting the energy to electrical signals.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department, expanding the diagnostic possibilities of CT at the patient’s bedside.

“The OmniTom Elite is an advanced imaging solution that is extremely mobile, giving healthcare providers more flexibility in when and where they run diagnostic tests for their patients,” said Renaud Maloberti, Vice President, Head of Business, MCT. “We look forward to featuring this innovative technology at this year’s Radiological Society of North America Annual Meeting.”

NeuroLogica will showcase its innovation at Booth #6133, McCormick Place, and unveil the OmniTom Elite with PCD on Sunday, November 26 at 10:30 am CST, with a live demonstration of this state-of-the-art technology.

Also on Sunday, November 26 from 11:45 am to 12:45 pm CST in the South Building, Level 4, Room S403B, McCormick Place, Dr. Raj Gupta of Massachusetts General Hospital and Professor Iris Grunwald of the University of Dundee host the Samsung NeuroLogica Lunch & Learn Event “Photon Counting: The Next Generation of Neuro CT.” They will discuss how leveraging the latest innovation in CT applications may increase productivity and enhance the patient and physician experience.

For more information or to register, visit www.eventcreate.com/e/samsungrsna2023.

▲ The ISUOG World Congress will be held in Seoul, Korea from October 16 to 19

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, will be showcasing its AI-based diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) World Congress 2023 held in Seoul, South Korea from October 16 to 19.

As one of the most important academic societies in the field of obstetric and gynecologic ultrasound, ISUOG organizes annual congresses worldwide to share the latest technology and research findings. This year’s event, held for the first time in Seoul, will be attended by nearly 2,000 obstetricians and gynecologists from 126 countries.

Samsung Medison, a main sponsor of the event, will showcase Samsung’s AI diagnostic technology through the display of its premium ultrasound systems “HERA W10 Elite” and “V8,” diagnostic solution demonstrations and a symposium.

▲ Samsung Medison’s HERA W10 Elite(left) and V8 will be exhibited at ISUOG 2023

HERA W10 Elite is a premium ultrasound system equipped with a 27-inch OLED monitor, which exhibits less brightness variation across viewing angles than conventional LCD monitors. Its probe delivers superior resolution, allowing users to view high-contrast ultrasound images from various angles without compromising image quality.

At the conference, Samsung Medison will showcase AI-based diagnostic assistant solutions, including HeartAssist, which categorizes and provides measurement results for fetal heart diagnosis with a simple press of a button; and UterineAssist, which automatically measures the size and shape of the uterus helping to accurately examine and diagnose the uterus.

In addition, Samsung Medison will present AI-automated measurement functions such as BiometryAssist and ViewAssist, which measure and automatically annotate fetal growth indicators by extending the items previously measured only in the 2nd trimester (14-27 weeks) to the 1st trimester (1-13 weeks) in accordance with the newly revised ISUOG guidelines in February 2023.

“Using the BiometryAssist feature, fetal weight can be measured with professional accuracy up to 48 hours before delivery, and the measurement time can be dramatically reduced,” said Professor Mar Gil of Torrejón University Hospital, Spain, in an abstract of the study available for publication at the conference.

At the conference, Samsung Medison will also introduce an upgraded version of “5D CNS (Central Nervous System)+,” a convenient feature for fetal brain examination.

A positive reception is anticipated at the conference due to its automatic provision of nine essential cross-sections of the fetal brain, including the coronal and sagittal planes and six measurements necessary for diagnosis – head circumference and diameter, with high accuracy.

Other features such as SonoSync, which specializes in remote consulting and training, and S-Hub, an IT solution for hospital resource management, will be on display to medical professionals from around the world.

Samsung Medison will hold symposia on “Obstetrics” and “Gynecology” on October 17 and 18, respectively, to present research findings on the clinical utility of features that help diagnose the heart and brain of a fetus and endometriosis.

During the “Fetal Therapy and Telesonography” session in the “Obstetrics” symposium, Dr. Ruben Quintero from The Fetal Institute in the United States will present a case where SonoSync, a real-time ultrasound image-sharing solution with remote control ability, saved the life of a mother and her newborn in a case of misdiagnosed fetal distress.

In the “Gynecology” symposium, Professor Tom Bourne from Imperial College, U.K., will present his research on ovarian tumors using CrystalVue and MV-Flow features.

“Samsung is continuously developing AI technologies that improve diagnostic efficiency so that doctors can focus more on patient care,” said Jinyong Lee, Head of the AI Vision Group at Samsung Medison. “We are continually striving to develop technologies that can be utilized in the field of obstetrics and gynecology to contribute to improving maternal and fetal health.”

The conference, which is held for the first time in South Korea, is also the first offline event since the end of the COVID-19 pandemic. Samsung Medison is participating as the main sponsor and engaging in various academic activities, including the Samsung-ISUOG webinars and the Pre-Congress.

▲ ISUOG Industry Webinar schedule

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit www.samsunghealthcare.com.

During this congress, Samsung will be showcasing the clinical values and efficiencies of the Artificial Intelligence (AI)-based diagnostic solutions through various scientific programs.

Samsung’s symposium will be held on September 18^th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions: BiometryAssist which measures the growth and condition of a fetus and HeartAssist which improves workflow when diagnosing a fetal heart.

Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSync, a real-time ultrasound image-sharing solution during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome from the ISUOG venue in London.

“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in ultrasound environment using SonoSync brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”

In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high performance diagnostic solutions such as MV-Flow which is used to visualize the slow flow of microvascular structures and the existence of micro-blood-flow.

The onsite scientific programs, Samsung will display online webinars at six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and the Samsung’s Healthcare website (www.samsunghealthcare.com).

Samsung will also showcase its premium ultrasound system for obstetrics and gynecology known as HERA W10 and V8 which systems includes Intelligent Assist (AI diagnostic solutions), as well as V7, high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.

As far as the name, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology and more. The V7 hosts features and solutions seen on premium ultrasound systems.

※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.

Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison stated “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals. We will continuously proceed forward introducing diagnostic solutions for the medical professionals and patients.”

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Exhibition products at ISUOG 2022 (from left — V7, HERA W10, V8)

SonoSync — Solution to overcome spatial constraints when performing ultrasound exams

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

“Since the launch of the ‘Intelligent Assist’ solution in 2020, we have been actively listening to the needs of our customers and have reflected the needs of the market into our enhanced AI-based image processing technologies and diagnostic assistance functions,” said Won-Chul Bang, Vice President, Head of Customer Experience Team at Samsung Medison. “We will actively introduce various ultrasound diagnosis solutions to meet customers’ needs in the future preemptively.”

Samsung is launching its enhanced ‘Intelligent Assist’ software in its premium ultrasound device, HERA W10, and will be presenting its clinical values for “Improving Accuracy and Efficiency” for fetal anomaly detection using its AI solutions during the online symposium on October 17^th.

‘Intelligent Assist’ solution includes ‘Biometry Solution’ for assessment of the fetal growth and ‘Fetal Heart Solution’ for the assessment of the fetal heart.

‘Biometry Solution’ recognizes images such as the fetal head, abdomen, lower extremities and others and measures the fetal growth and development while the ‘Fetal Heart Solution’ recognizes the view of the fetal heart, annotates the images and measures the necessary fetal heart structures for a thorough fetal heart anomaly assessments.

During the symposium, Aris Papageorghiou, Clinical Research Director of the Maternal and Perinatal Health Institute at Oxford UK and the professor in obstetrics and fetal medicine at St George’s University Hospitals UK, will be introducing his clinical experiences with Samsung’s ‘Intelligent Assist’ solutions.

Hye-Sung Won, professor of the Department of Obstetrics and Gynecology at Asan Medical Center, Korea, will introduce the MPI+ that semi-automatically measure LV MPI and RV MPI to analyze the fetal heart function. She will also be presenting her findings of the feasibility and reliability of ‘Fetal Heart Solution’ in automatically providing complex fetal heart view image classifications and fetal heart structural measurements.

In addition, Samsung will be introducing its high-end versatile ultrasound device ‘V8’, first released on September 30^th, at the virtual exhibition hall during ISUOG 2021.

‘V8’ will include some of the enhanced solutions that are dedicated to the premium ultrasound system such as MV-Flow, a novel alternative to power Doppler for visualizing the slow flow of micro-vascularized structures, and LumiFlow, three-dimensional visualization of blood flow which helps the user understand the structure of small vessels intuitively. ‘V8’ will also include some of the ‘Intelligent Assist’ solutions to cater to the needs of the larger busy hospitals.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

The image delineates that the fetal head is automatically recognized and measured along with the fetal growth when ‘Biometry Solution’ is executed.

The feature automatically recognizes and annotates the anatomy of the fetal heart and displays measured values when the ‘Fetal Heart Solution’ is executed.

About Samsung Medison
Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

“It’s very meaningful to launch the V8, a new premium medical device that addresses many customer needs,” said Won-Chul Bang, Vice President, Head of Customer Experience Team, Samsung Medison. “We expect V8 to become a flagship product of premium ultrasound systems as it is uniquely designed to cover different medical specialties.”

V8’s “V” stands for “Versatile,” meaning that the advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics and cardiology have been implemented.

Several diagnostic assistance functions of a premium ultrasound system for obstetrics and gynecology include MV-Flow which is suitable for observing the presence of microvascular blood flow, low-velocity blood flow and LumiFlow which provides three-dimensional visualization of blood flow in a two-dimensional image, allowing the medical staff a more realistic assessment of the vascular structures and flow.

For radiology, V8 is equipped with S-Shearwave Imaging which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity. V8 also features S-Fusion which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI which are instantly reconstructed in the corresponding plane.

On the other hand, it is also expected to be equipped with a NerveTrack which has been cleared by the U.S. Food and Drug Administration (FDA) as an AI medical device and can be used to treat musculoskeletal diseases that track nerve locations in pain areas in real time.

In addition, by introducing a 23.8″ LED monitor and a 14″ high-sensitivity touch panel, user convenience has been enhanced to perform various procedures.

The screen that automatically tracks the nerve’s location on the wrist in real time with the NerveTrack function is executed.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

Samsung Electronics will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2020 Annual Meeting from November 29 to December 5.

“This year has been a pivotal year for Samsung in moving forwards new solutions across a variety of areas. We are looking forward to putting on display our advancements within ultrasound, digital radiography and mobile CT modalities,” stated Yongkwan Kim, Head of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Our innovative solutions demonstrate Samsung’s commitment to leveraging our innovation engine to better address the needs of healthcare providers and their patients.”

Ultrasound

Samsung will showcase the RS85 Prestige, which is designed to deliver outstanding scanning performance with consistent image clarity, depth of penetration and sensitivity to perfusion of blood flow to enhance abdominal and breast examination functionality. Above all, the RS85 Prestige delivers real-time images to clinicians, which is essential in ultrasound imaging.

New features:

• EzHRI assists in diagnosing fatty livers by showing the degree of the fatty liver after analyzing the ultrasound images and comparing the brightness level of the automatically selected location of hepatic parenchyma and renal cortex.
• TAI (Tissue Attenuation Imaging), TSI (Tissue Scatter distribution Imaging) provide quantitative tissue attenuation measurement and tissue scatter distribution measurement to assess steatotic liver changes.
• LA2-14A is an S-Vue Transducerwith single crystal technology, providing clear distinction in images of anatomical structures based on high SNR and deep penetration. As a single crystal transducer added to the high-resolution imaging technology, Crystal Architecture, useful images are provided for diagnosing thyroid and breast tumors as well as MSK tendon-related disorders.

Additional features deliver simplified workflow and accurate diagnoses:

• S-Detect simplifies breast examination processes by providing analysis of the selected lesion and standard reporting based on BI-RADS ATLAS*(Breast Imaging-Reporting and Data System, Atlas).
• S-Shearwave Imaging allows for non-invasive assessment of the stiffness of tissue/lesions in applications such as breast, liver, MSK and prostate, aided by color-coded elastogram, quantitative measurements, dual or single display options, and user-selectable ROI functions. It aids in the diagnosis of hepatocirrhosis and tumors.

Digital Radiography

Samsung is showcasing its premium digital mobile x-ray, the AccE GM85, which delivers unparalleled performance by improving diagnostic confidence and workflow. The AccE GM85, powered by a lithium-ion battery, in particular has demonstrated unprecedented performance during the recent pandemic. The AccE GM85 is suited to general imaging needs, and its practicality during the COVID-19 pandemic is highlighted through its unique feature set.

• Fast charging and long-lasting battery allows full charge within four hours, and the power to keep going all day without need for additional charging. With Li-ion battery technology, it offers enhanced stability in wider temperature ranges and its lead-free composition is more friendly for the environment.
• SimGrid streamlines workflow and reduces the total exam time by 28% by omitting grid installation and removal from the conventional workflow.
• S-Vue provides better image quality and significantly reduces radiation dosage during exams. The dosage can be reduced by up to 45% for pediatric abdomen, 15.5% for pediatric chest, and 27% for pediatric skull exams with the new S-Vue engine.¹

Samsung will be introducing two new enhanced software options for its line of DR equipment, including:

• Value Up Package 2021, a suite of workflow enhancement and diagnostic tools for Samsung DR systems including an AI algorithm that automatically provides a heads-up view of chest AP/PA; enhanced S-Align function with information of tube and detector angle to DICOM; and many other tools to deliver improved clinical care.
• Mirror View, real-time wireless screen mirroring to a Smart TV or Miracast-enabled display for use within an ER/Trauma or operating room environment.

Computed Tomography

Featured at RSNA are BodyTom^® Elite and OmniTom^® – mobile whole-body and head CTs. These mobile CTs can be used at the point of care, whenever imaging is needed to determine the ideal treatment strategy for a patient – without restrictions of physical space and power. Samsung’s NeuroLogica mobile CT devices are used by numerous leading institutions in intensive care units, emergency rooms, orthopedic and neurosurgery rooms, brachytherapy suites and ambulances.

In addition, Samsung will be presenting a Photon Counting Detector (PCD)² – cutting-edge technology that measures photons emitted by X-rays. The PCD, currently under development, has the potential to allow for dose optimization, allowing the user to reduce exposure while maintaining image quality, or increase the image quality by keeping dose equivalence compared to currently used CT detectors. The PCD is expected to deliver increased data mining capabilities from multiple-energy detection and contribute to the improved utility and efficacy of AI applications. Expanding from this, Samsung is closely collaborating with a major university hospital in the United States.

Samsung will host three Industry Sessions during RSNA:

• Featured Demonstration about advanced imaging technologies with RS85 Prestige will be held on December 3, from 5:00 p.m. CT – 5:30 p.m. CT.
• AI Theater Presentation: Application of On-Device AI in Healthcare, in collaboration with Intel,³ will discuss On-Device AI solutions that provide real-time feedback on ultrasound images and protect patients’ personal information. As a part of this collaboration, Samsung will host an Industry Session to address the differences between Cloud AI and On-Device AI, and the significance in ultrasound, available on demand throughout the duration of RSNA.
• Innovation Theater will highlight the performance of Auto Lung Nodule Detection (ALND)⁴ imaging application on chest radiographs of COVID-19 patients, available on demand throughout the duration of RSNA.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

¹ The S-Vue outcome is based on limited phantom and clinical study results. Only routine PA chest radiography and abdominal radiography for average adults and pediatric abdominal, chest, skull radiography were studied, excluding pediatric patients under 1 month old. (FDA cleared – K172229, K182183) In practice, the values of dose reduction may vary accordingly.

² Product is under development and not available for sale in USA or any region of the world.

³ Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.

⁴ ALND is not available for commercial sale in the USA.

Examinations for women with high risk pregnancy, early diagnosis of fetal abnormalities, and automatic measurement solutions in ultrasound for delivery—quality healthcare solutions enabled by Samsung Medison—have been acknowledged and noted in the medical profession.

The devices will be showcased on an online platform prepared for the virtual event, which will feature webinars, virtual exhibitions and chat tools. Samsung Medison will display its new HERA series of ultrasound devices (HERA W10, HERA I10, HERA W9) featuring its new advanced technologies and solutions. The various Intelligent Assist solutions, elaborating on the details will be presented in a video format.

The solutions which expand across the full spectrum of diagnostic functions and capabilities include the following:

• BiometryAssist – Measures the fetal growth index quickly and confidently with the view that has been acquired semi-automatically.
• HeartAssist¹ – Helps to measure and provide a suitable guideline view for an early finding of congenital heart abnormalities for the fetus before it is born, utilizing deep learning.
• LaborAssist – Allows easy discovery of changes over the measured time, and provides demo video and animation images for clear explanation and communication of the delivery process to the mothers.

BiometryAssist and LaborAssist are expected to simplify the user’s workflow by not only reducing simple repetitive manual tasks, but also increasing measurement accuracy and providing consistent measurements.

These two features have been developed by incorporating the Intel Distribution of the OpenVINO toolkit into Samsung’s diagnostic algorithm. By using the OpenVINO toolkit, powered by Intel processors, data processing moves at a speed 4.7 times faster than equipment without the OpenVINO enhancements.²

“Our Intelligent Assist solutions enhance patient comfort and clinician’s convenience, reduce scan time, improve diagnosis accuracy, and increase system throughput. Samsung will continue to develop the next-generation ultrasound solutions in collaboration with Intel for the ongoing development of Intelligent Assist solutions,” announced Won-Chul Bang, Vice President of Health & Medical Equipment Business, Samsung Electronics and Samsung Medison.

The event also includes three rounds of webinars, during which world prominent OB/GYN specialists will share the clinical results of various diagnostic tools, including MV-Flow, LumiFlow and CrystalVue, which are available in the HERA series.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Intel, the Intel logo, and OpenVINO are trademarks of Intel Corporation or its subsidiaries.

The screen that automatically recognizes and annotates the heart on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

The screen that automatically recognizes the heart and displays measured values on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

¹ 510(k) pending at FDA

² Source: Internal Samsung testing.
System configuration: Intel Core i3-4100Q CPU @ 2.4 GHz, 8 GB memory; OS: 64-bit Windows 10.
Inference time without OpenVINO enhancements was 480 milliseconds. Inference time with OpenVINO enhancements was 85 milliseconds.

Samsung Electronics is showcasing the latest diagnostic imaging medical equipment and AI-based solutions at ECR 2019 – European Congress of Radiology in Vienna, Austria. At booth #406 (Expo. X4), Samsung is displaying a variety of diagnostic imaging equipment, especially, the X-ray zone, which was designed and inspired by pediatric wards, features a new low dose imaging processing engine for children.

“We are pleased that Samsung’s AI technologies have been successfully applied to the existing diagnostic imaging devices and have been well received in the market,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to deliver on our promise of fast, easy and accurate diagnostic solutions for our customers in the healthcare community.”

Samsung is continuing to expand its boundaries in finding new solutions in radiology ultrasound. At ECR 2019, Samsung will introduce its solutions for breast screening and real-time streaming solutions in ultrasound including:

■ Breast Screening Solutions

• S-Detect for Breast is an AI-based software which analyzes breast lesions using ultrasound images. It assists in standardizing reports and classification of suspicious breast lesions by incorporating BI-RADS® ATLAS (Breast Imaging-Reporting and Data System, Atlas) into the tool. When the user selects a region of interest, S-Detect for Breast analyzes the selected lesion and provides lexicon classification options with a streamlined workflow.

• S-Shearwave Imaging allows for non-invasive measurement of the stiffness of tissue/lesions in the breast, by providing an advanced level of diagnostic information. The color-coded elastogram, quantitative measurements (in kPa or m/s) are especially useful to healthcare professionals for making an accurate diagnosis of breast diseases. The reliability of the result is highly improved by providing the RMI (Reliable Measurement Index)

• MV-Flow offers a novel alternative to Color Doppler for visualizing slow flow microvascularized structures. High frame rates and advanced filtering enable MV-Flow to provide a detailed view of blood flow in relation to surrounding tissue or pathology of suspicious breast lesions.

• ElastoScan+ is an ultrasound technology for imaging elasticity. It detects the presence of solid breast masses in tissues and converts any stiffness into color images. Samsung provides semi-quantification assessment designed to enable quick and easy calculation of the strain ratio.

■ Real-time Ultrasound Image Sharing Solution

• SonoSync provides a real-time streaming network service that overcomes the spatial limitations of conventional ultrasound exam operations. Compared with general video sharing solutions, it also has the advantage of supporting bidirectional communication such as voice chat and marking.With SonoSync, clinicians on both sides can simultaneously review the shared images and have discussions during the examination. SonoSync can be simply used without any additional hardware for ultrasound scanners and can be easily connected with various devices such as smartphones, tablets, laptops, and desktop PCs.

Samsung recently announced that the U.S. Food and Drug Administration (FDA) has approved pediatric low dose across its entire digital X-ray portfolio.

“We are excited to expand our commitment on patient safety with the addition of U.S. FDA clearance for pediatric low dose that may improve dose care without compromise to image quality,” said Insuk Song, Senior Vice President of Health & Medical Equipment Business at Samsung Electronics. “Samsung is constantly working on pediatric-centric innovation to uphold ALARA (As Low As Reasonably Achievable) principle for minimizing radiation dose. Our dedication to pediatric care conveys the effort keep the long-term safety of children who are more sensitive to radiation and its cumulative effect.”

■ Dose Less Care More: From The Very Start

• S-Vue delivers high-resolution images through advanced processing technology. Especially, spatially adaptive multi-scale processing and advanced de-noising technology preserve the image quality at high standards despite the reduced dose of radiation. The advanced noise reduction algorithm in the S-Vue imaging processing engine cuts dosage by 45% to a low dose level for pediatric abdomen exams without sacrificing image quality¹.

Without worries of additional settings or exposure, you can easily improve the clarity of the clinical images to boost your diagnostic confidence empowered by Samsung’s unique post-processing feature, SimGrid.

• SimGrid allows you to provide better patient care with higher satisfaction and reduced retake rates without the use of a portable grid. It improves image contrast by reducing scatter radiation effects and creates better image quality.

Samsung is also presenting the mobile CT OmniTom^® and a prototype of Extremity MRI using Media Wall.

At the AI room of the event, visitors can learn about Samsung’s AI technology more easily. Samsung will also host a satellite symposium that will present clinical research using Samsung’s contrast-enhanced ultrasound technology and Pediatric DR Imaging for Patient Safety.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

¹ FDA 510(k) clearance: The non-clinical and clinical image evaluations show that the proposed devices with the new IPE (Image Post-processing Engine) employing and advanced noise reduction algorithm are able to reduce x-ray dose up to 47.5% for abdominal radiographs of average adult and up to 45% for pediatric abdomen, 15.5% for pediatric chest, and up to 27% for pediatric skull exams, compared with radiation doses needed to obtain similar image quality using the old IPE on the same x-ray systems.

Samsung Electronics, a leader in medical imaging technology, is showcasing its latest Ultrasound, Digital Radiography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) concept and their software innovations at the Radiological Society of North America (RSNA) 2018 Annual Meeting at McCormick Place in Chicago.

“We are pleased that Samsung’s AI technologies have been successfully applied to the existing diagnostic imaging devices and have been well received in the market,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “As a comprehensive diagnostic imaging solution provider, we will continue to strengthen our technologies through collaboration with hospitals and healthcare professionals. We aim to bring together radiologists and AI to fill in the gaps for improved healthcare management.”

Samsung showcases several types of AI based diagnostic imaging software:

• Ultrasound System – S-Detect for Breast is AI based software which analyzes breast lesions using ultrasound images, and has been implemented into Samsung’s ultrasound systems dedicated to Radiology. It assists in standardizing reports and classification of suspicious breast lesions by incorporating BIRADS® ATLAS* (Breast Imaging-Reporting and Data System, Atlas)

According to a recently published study¹ by radiology professor Tommaso Bartolotta from the University of Palermo in Italy, S-Detect for Breast has shown to assist various degrees of improvement in the overall diagnosis of breast lesions. When using S-Detect for Breast, the diagnostic accuracy for doctors with experience of four years or less improved from 0.83 to 0.87 (AUC, Area Under Curve). S-Detect for Breast could be a useful tool for supporting and guiding breast diagnosis among non-expert breast imaging physicians (Only shape and orientation descriptors are automatically classified in the United States).

• Digital Radiography – By using AI technology, the ‘Bone Suppression’ function, which reduces the bone signal from the chest x-ray image, clearly brings out the lung tissues obscured by the bones. ‘SimGrid’ has also been introduced as a solution to ease the workflow to replace grids, while providing excellent image quality with reduced scatter artifacts. According to a recently published study², ‘SimGrid’ provided image quality almost as good as the images taken with a physical grid.

The Auto Lung Nodule Detection (ALND) is a CAD (Computer Aided Detection) solution based on AI technology used in the detection of lung nodules and is 510(k) pending. According to a recent  study³in press in Journal of Thoracic Imaging, ALND improved the detection sensitivity of lung cancer nodules 3 cm or smaller in chest radiographs by seven percentage points to 92 percent, compared with the average of six chest radiologists.

• Computed Tomography – Samsung has introduced the intra-cranial hemorrhage package that combines a mobile stroke unit with a radiological computer aided triage and notification solution based on AI technology.

• Magnetic Resonance Imaging – Utilizing AI technology, Samsung is developing a technology to display information such as knee cartilage thickness as well as images of knee arthritis patients. The software is a prototype and not for sale in any region of the world.

At the Samsung booth, attendees will find a separate ‘AI zone’ that allows visitors to experience Samsung’s AI technology more easily. Samsung will also host a symposium that will demonstrate how its image processing technology improves diagnostic accuracy and promote radiation safety for pediatric patients.

Through the release of new diagnostic tools that utilize diverse data based on AI technology, Samsung will continue to support healthcare professionals to improve the diagnostic accuracy.

For more information on Samsung’s healthcare business, and products, please visit https://www.samsunghealthcare.com.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

¹Tommaso Vincenzo Bartolotta, et al. Focal breast lesion characterization according to the BIRADS US lexicon: role of a computer aided decision making support. La radiologia medica. 2018 Mar 22

²S. Y. Ahn, et al. The Potential Role of Grid-Like Software in Bedside Chest Radiography in Improving Image Quality and Dose Reduction: An Observer Preference Study. Korean J Radiol, 2018; 19(3):526-533

³M.J. Cha, et al. Performance of Deep Learning Model in Detecting Operable Lung Cancer with Chest Radiographs. J Thorac Imaging, 2018 In press

Samsung showcases premium new ultrasound systems ‘HERA W10’ and ‘HERA I10’ at ISUOG World Congress 2018

HERA is a new premium platform which stands for Hyper-aperture Enhanced Reconstruction Architecture, incorporating Samsung’s new Crystal Architecture to provide advanced technology and capabilities with a new level of image quality. Samsung’s new platform combines Crystal Architecture with an advanced transducer technology called S-Vue. It allows an 11-fold increase in processing power and 10 times the data transfer speed of Samsung’s previous system. It is expected to facilitate the examination of high-risk pregnancies and early diagnosis of abnormal fetus conditions.

“Samsung is proud to introduce a new premium ultrasound system HERA W10 and a form factor innovation ultrasound HERA I10, as well as solutions that greatly improve the efficiency of hospitals,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to provide the best solutions possible and bring meaningful changes in the healthcare industry.”

New features for Samsung’s HERA W10 ultrasound system offer clinicians an optimized workflow and more information to overcome challenges, including:

Outstanding Image Quality

• Crystal Architecture – Offers a superior image with single crystal probe technology S-Vue, a new beamforming technology CrystalBeam and an advanced post-processing engine CrystalLive.
• ShadowHDR – Provides a shadow suppressed image, especially applicable to highly attenuated regions such as fetal head and spine.
• HQ-Vision – Allows users get high resolution images to detect clinically important details.

New Samsung Exclusive Technologies

• MV-Flow – Offers a detailed view of blood flow in relation to the surrounding tissues or pathology with an enhanced spatial and temporal resolution.
• LumiFlow – Provides a three-dimensional visualization of continuous and volumic vascular image.

Seamless Workflow

• Wide Control Panel – Adopted rotatable control panel with a top-notch swivel mechanism. Allows moving range of 550mm from left to right and 219mm from top to bottom.
• Touch Customization – Allows users to easily change the position of the button on the touchscreen for each mode and feature.

In addition to HERA W10, Samsung is unveiling a prototype of HERA I10, which shares the same platform as HERA W10, but with a completely new ergonomic redesign. HERA I10 is a next-generation chair-type ultrasound system with a design that is entirely different from the industry norm that meets the unique needs of Ob/Gyn professionals. HERA I10 provides a comfortable experience for both the doctor and the patient by addressing the discomfort caused by the spacing and the position of the clinicians and eliminating the need for the patient to shift the body, as it automatically adjusts for proper positioning. It also reduces the force required to move the control panel back and forth and the resistance force on the wrist.

A new ultrasound solution SonoSync will also be introduced, which allows healthcare professionals to see real-time ultrasound scanning images in remote places¹. SonoSync provides two-way communications through voice chatting and marking, improving accessibility. It can be installed on various devices such as smartphones, laptops and desktop PCs, allowing multilocation real-time training and education among healthcare professionals. Its Multiview feature also increases productivity by viewing multiple image scans in one screen.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

¹SonoSync may not be used for diagnostic purposes at all times. Its availability may vary in different countries, according to regulatory approvals.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, is showcasing its latest ultrasound systems at EUROSON (30^th Euroson Congress of the EFSUMB) from September 6^th to 9^th in Poznan, Poland. At booth #5 (Hall 15), Samsung is displaying RS85, the latest ultrasound system with integrated solution and sophisticated imaging technology. Samsung will also debut its new solution SonoSync, which offers real-time communication between clinicians.

“We are excited to showcase the latest version of our premium ultrasound RS85. Samsung now offers a comprehensive portfolio of diagnostic ultrasound systems with exceptional image quality and better workflow to meet the needs of clinicians,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Our solutions and products continue to prove their versatility as more healthcare providers find new innovative ways to use them.”

Within ultrasound systems, Samsung has made great achievements in obstetrics and gynecology and will continue to expand its portfolio to other segments such as radiology. At EUROSON, product specialists will be on hand demonstrating a wide range of ultrasound systems that are designed to help healthcare providers find effective clinical pathways. Samsung will showcase a number of ultrasound systems including:

• RS85 – Radiology-designated ultrasound system featuring MV-Flow technology, which detects microvascular blood flow. Its S-Shearwave Imaging feature provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT.

• HS70 – High-end ultrasound system specifically designed to fit into radiology and cardiovascular solution. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave technology measures the elasticity of mass to help the diagnosis of liver lesions and RealisticVue is an additional feature that improves 3D image quality.

• HS60 – Equipped with a compact design, a 21.5-inch full high definition side display and touch screen. It also features HQ-Vision, which allows users to get a high-resolution image that helps detect clinically important details. S-Harmonic uses multi-frequency to provide a clear image from near zone to far zone.

• HS40 – Ultrasound system with user-friendly design and convenient workflow providing efficient and effective care. Features include ClearVision, MultiVision, EZ-Exam+ and ElastoScan, which helps detection of lesions.

Samsung’s new ultrasound solution SonoSync is a software that provides network service which transmits real-time ultrasound examinations¹. With SonoSync, clinicians on both sides can simultaneously view the image scanned by sonographers and share markings during discussion. This software can be simply installed without HDMI hardware boxes. Samsung’s SonoSync can be easily connected to various appliances such as smartphones, tablets, laptops and desktop PCs, increasing utility for clinicians’ teaching and training.

For academic seminars, Samsung Electronics Poland branch is hosting a satellite symposium through recent studies with leading professionals. EFSUMB Congress President Professor Paul Sidhu will present on the role of elastography in liver fibrosis: techniques, clinical practice and guidelines. Professor Wojciech Kosiak of the Pediatric Radiology Department at University of Gdańsk will speak about the possibilities of ultrasound in different diagnosis of focal liver lesions in children.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

¹ SonoSync is not for diagnostic use. Its availability may vary in different countries, according to regulatory approvals.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

At booth #506 (Expo. X5), Samsung is displaying medical equipment based on its ‘AccE’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed. Samsung also seeks to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“Samsung is committed to medical advancements for both diagnostic solutions and patient care. We will continue to develop optimized medical equipment to healthcare providers by combining our key values in the pursuit of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison.

Within ultrasound systems, Samsung has made great achievements in Obstetrics and Gynecology and will continue to expand its portfolio to the radiology segment. At ECR 2018, Samsung will present upgraded ultrasound systems including:

• RS85, Samsung’s advanced premium ultrasound system for radiology that provides enhanced image quality and convenience for medical and radiology professionals. The RS85 features MV-Flow technology, which detects blood flow in the microvascular, and S-Shearwave Imaging, which provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and also allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT for easy and fast biopsy.

• HS70A with Prime, the high-end ultrasound system specifically designed to fit into a general ultrasound imaging setting from routine to complex. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave and Realistic Vue are additional features that improve image quality.

Samsung will also introduce digital radiography solutions that manage the dose for patients and meet the needs of healthcare providers, including:

• GC85A, which provides outstanding images that boost diagnostic confidence equipped with technologies such as S-Detector and S-Align. The device adopts Low Dose technology for enhanced patient safety. Samsung recently cleared in the U.S. FDA for 50% dose reduction in adults’ chest exams, using GC85A with the new imaging engine S-Vue3.02.

• GM85, a lighter version of original GM85 will be displayed. The weight is reduced, but the functional benefits such as enhanced mobility and streamlined workflow are still retained. GM85 provides advanced patient care through leading edge imaging functions.

At the Beyond Experience Zone, visitors can learn about Samsung’s efforts in supporting radiologists in their diagnoses through various software technologies such as SimGrid^TM, Bone Suppression and Dose Reduction. In addition to superb medical equipment, healthcare providers can visit the Low Dose Campaign Zone and experience how low the radiation dose of GC85A is compared to real life radiation through the Low Dose Quiz.

Samsung Electronics’ subsidiary NeuroLogica will showcase innovative mobile CT OmniTom^®, which features an array of improvements from Samsung’s award-winning CereTom^® CT scanner. OmniTom^® is ideal for cranial procedures and is designed to deliver high-quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients. Samsung will also show its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology.

Samsung is also presenting a prototype of Extremity MRI, which is expected to be a game changer in the industry. It is designed to improve not only cost and space efficiency but also patient convenience, as it reduces the need for the whole body to be in the MRI device to scan extremity areas such as arms and legs.

In addition to showcasing its portfolio of comprehensive healthcare solutions, Samsung will be hosting two satellite symposia throughout the week at ECR. Samsung’s symposia will highlight the key trends and issues across ultrasound imaging and digital radiography technologies.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com/.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today introduced the RS85, a new premium ultrasonic diagnosis device that provides enhanced image quality, usability, and convenience for medical and radiology professionals.

“We are pleased to launch the RS85, a new premium medical device with superior image quality and usability based on Samsung’s advanced ultrasonic and radiology technologies,” said Insuk Song, Vice President, Health & Medical Equipment Business, Samsung Electronics. “We have high expectations the RS85 will make inroads into the global radiology market as Samsung Medison’s representative product. We will continue to diversify our product portfolio for different medical applications and sectors.”

Among its features, the RS85 features the MV-Flow and S-Shearwave Imaging technologies. The MV-Flow is able to detect the blood flow in microvascular tissues which is hard to be detected via a conventional Doppler ultrasonic wave. This allows researchers to check for indication of any type of lesion related to cancer or inflammation. The S-Shearwave Imaging feature provides new indicators for clinical diagnosis by quantifying the elasticity of human anatomy via shear wave elastography which will increase the accuracy of diagnosis for diseases such as hepatocirrhosis and tumors.

Furthermore, the RS85 is equipped with CEUS+ for diagnosing blood flow or lesions using contrast agent images, and also provides expanded diagnostic range to the liver and breast areas as well as safe, accurate diagnosis for young children. The S-Fusion function extends analysis to the prostate gland, and also allows coordination and simultaneous comparative analysis of images and sonograms from other diagnosis instruments such as MRI and CT.

The RS85 also has a monitor arm that can reach even wider areas compared to Samsung’s conventional products. Also, the RS85 has been developed to decrease the fatigue of sonographers by adding a touchscreen for easier control of the device, and it can reduce the scanning time to improve usability.

Samsung Medison, which has achieved great results in ultrasonic diagnosis devices for obstetrics and gynecology, is strengthening the premium ultrasonic diagnosis device business for radiology. Based on the RS85, the company will continue to expand its products in large hospitals, and enhance research cooperation with medical experts around the world.

The RS85 will be available first in Korea and Europe in November, with more markets to follow.

UOG is the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). The image that the publication selected represents a breakthrough for Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics. Its fetal echocardiography technology called 5D Heart Color allows a precise diagnosis of congenital heart disease.

The clinical image was obtained from a 26-week fetus with hypoplastic left heart and coarctation of the aorta, in which nine standard fetal echocardiography views with automatic labeling were displayed on a single screen.

The story behind the image can be found in a research paper led by Prof. Roberto Romero, Chief of the Perinatology Research Branch of the National Institute of Child Health and Human Development (NICHD)/National Institutes of Health in the U.S., and Prof. Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S.

According to the research, the Picture of the Month illustrates how the cardiac diagnostic planes shown by 5D Heart Color (i.e. color Doppler FINE – Fetal Intelligent Navigation Echocardiography) allowed a precise diagnosis of hypoplastic left heart with coarctation of the aorta, and that such planes demonstrated evidence of abnormal fetal cardiac anatomy and hemodynamic flow.

The publication stated, “The characteristic features of this congenital heart defect were visualized in the seven echocardiography views. In the four-chamber view, the left side of the heart was severely hypoplastic with absent flow through the atretic mitral valve, and the aortic arch view showed a very narrow transverse aortic arch (coarctation) with reversed color Doppler flow in this area and the isthmus.”

Samsung’s 5D Heart Color provides nine different fetal echocardiography views containing clinically useful information about cardiac structure and function, including the three vessels and trachea view, four-chamber view, left and right ventricular outflow tract views, aortic arch view, and four others. In cases of congenital heart disease, since abnormal fetal cardiac anatomy and hemodynamic flow characteristics are depicted, this enhances the diagnostic potential of the technology. In addition, there is reduced operator dependency, and examination of the fetal heart is standardized and simplified.

As 5D Heart Color marks the second time Samsung Medison’s technology has been selected as Picture of the Month, (The company’s Crystal Vue also gained the honor in 2016) it’s an illustration of how Samsung Medison is continuing to establish its brand power in the global women’s health industry by providing technology with clinical value to medical professionals.

“It is exciting to see 5D Heart Color is being featured on the front cover of UOG, especially since the diagnostic accuracy of 5D Heart was presented at last month’s World Congress on Ultrasound in Obstetrics and Gynecology,” said Insuk Song, Vice President of the Health & Medical Equipment of Samsung Electronics. “Samsung will continue to focus on developing medical technology that can improve the detection of fetal congenital heart disease and contribute to saving more lives.”

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, is hosting a number of seminars at the 27th World Congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG) in Vienna. Through 13 sessions at Samsung’s Satellite Symposium, leading medical professionals are publicizing the clinical benefits of Samsung’s ultrasound imaging solutions for women’s health.

Professor Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S., presented research on the diagnostic performance of Fetal Intelligent Navigation Echocardiography (5D Heart) which showed a sensitivity of 98%, specificity of 93%, and accuracy of 95% for the prenatal detection of congenital heart disease*.  She also explained that 5D Heart offers a rapid and simple solution to screen for and diagnose congenital heart disease by generating nine standard fetal echocardiography views in a single template display.

Additionally, novel research conducted on color Doppler Fetal Intelligent Navigation Echocardiography (5D Heart Color) will be published in the October 2017 issue of the scientific journal Ultrasound in Obstetrics & Gynecology (UOG), which will also feature on its front cover, the prenatal diagnosis of congenital heart disease using 5D Heart color.

In addition recently developed diagnostic tools such as E-Cervix, Crystal Vue and IOTA-ADNEX from Samsung’s Crystal Clear Cycle, the lifelong healthcare solution for women, are also being presented throughout the congress.

Samsung also displayed prototypes of ultrasound system with new ergonomics and stress-relief transducers, as well as cloud-based IT solution at a private room for selectively invited key opinion leaders. Visitors to the room shared feedbacks that the next-generation product meets the needs of professionals and patients with a form that is entirely unlike the norm. Some also showed positive response to the new IT solution designed to provide efficiency for doctor’s demanding tasks, and that they look forward to its commercial release.

“I believe Samsung’s proactive technological developments in ultrasound in recent years are providing quite significant clinical value to the field. Samsung has been releasing machines for users at all levels of expertise,” said Dr. Andrew Ngu, former President of the ISUOG. “Seeing Samsung’s vision for design innovations that enhance user workflow and efficiency, it is not difficult to expect Samsung to play a pivotal role as a game changer for the future ahead.”

For additional information, [click here].

* Congenital heart disease is the most common organ-specific birth defect, and is also the leading cause of infant mortality from congenital malformations. The performance of conventional two-dimensional ultrasound of the fetal heart is time-consuming, requires considerable expertise and skill, and therefore is highly operator dependent. As a result, not all fetal cardiac views required for the accurate prenatal detection of congenital heart disease may be routinely obtained.

Samsung will highlight solutions that focus on providing ‘Improved Access and Enhanced Accuracy’ in order for radiologists and radiographers to perform more confident diagnosis and better patient care. By integrating its leading capabilities in form factor innovations, Samsung’s latest medical equipment helps users get to patients faster and easier with ergonomic design that is more compact and lighter. Latest upgrades in imaging features have also applied Samsung’s latest analytic algorithm and image enhancing technology to help radiologists make more accurate decisions with greater clarity.

“Samsung aims to offer what radiologists and clinicians most seek from diagnostic solutions and deliver technologies that meet their needs for easier access and greater accuracy,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Our commitment to European customers and radiologists around the world only grows stronger each year. Samsung is continuing to develop technologies that will bring new innovations to various medical environments.”

On display at Samsung’s booth are the following solutions:

Improved Access

The new award-winning mobile digital radiography GM85 offers an ultimate driving experience, and the CereTom® is utilized in a wide range of market applications such as mobile stroke units:

• GM85’s compact design & optimized workflow: Winning the 2017 iF Design Award, the GM85 equips with a slim, ergonomic design which allows easy access around tight spaces, even in elevators by its 555mm narrow width and about 40% lighter weight (at 349kg) than previous models. Applying Samsung’s world-class user-oriented design capability, the device offers a collapsible column which gives users clear visibility when moving the system and broadens access to smaller spaces. Its adaptive soft-driving control and front-bumper sensor also help make navigation safer. Moreover, the Quick-positioning allows handle-free, precise body movement by simple button clicks on the THU (Tube Head Unit).

• CereTom®, a portable CT scanner with versatility: The 8-slice scanner delivers rapid scan time and immediate image viewing with high-quality images in a variety of patient locations. The mobile stroke unit (MSU), a specialized ambulance or other emergency medical vehicle that is equipped with a CereTom®, allows the team onboard to quickly assess whether a patient is having a stroke caused by a blood clot or hemorrhage.

Enhanced Diagnostic Accuracy

The premium ultrasound system RS80A with Prestige and ceiling-type digital radiography GC85A offers cutting-edge features that enhance diagnostic consistency and accuracy:

• RS80A with Prestige’s latest key features: The CEUS+, Samsung’s latest contrast-enhanced ultrasound imaging provides superb resolution and improved uniformity with new transmit technology. It improves the diagnosis of small lesions through clear expression of tissue boundaries and assists users achieve easier and more accurate interventional procedures. The S-Detect for Breast helps radiologists understand characteristics of breast lesions to determine whether they’re malignant or benign in a few clicks with improved accuracy.

• GC85A improves image clarity and radiographer’s workflow: Bone Suppression improves clarity of soft tissue when suppressing the appearance of bones in chest images. As a result, nodule detection is improved to support diagnostic assessment. The device also features a new function which allows its operation without a portable grid, which not only reduces operator’s wrist overload but also eliminates alignment errors that often occur with portable grids, reducing retake rates.

Samsung Satellite Symposia

On Thursday 12:30-13:30 at Room X (2nd level), Samsung presents how advanced imaging technologies such as artificial intelligence and computer aided tool benefits in diagnosis, and on Friday 12:30-13:30 at Studio 2017 (1st level), clinical research using Samsung’s contrast-enhanced ultrasound technology will be held, respectively. Please visit here, for registration.

For more information, please visit www.samsungmedicalsolution.com.

“At this congress, Samsung is introducing a comprehensive diagnostic solution for women from family-planning to cancer screening, helping accurate diagnosis for health issues that women may experience throughout their lifetime,” said Dongsoo Jun, President of Health & Medical Equipment Business of Samsung Electronics and CEO of Samsung Medison. “Samsung is committed to creating solutions that provide clinicians with better imaging and help them make better management decisions for their patients. We see our collaboration with the International Society of Ultrasound in Obstetrics and Gynecology as integral to this.”

The key highlights at the congress include:

Total Solution for Women’s Health

• Crystal Clear — Defining women’s lifetime diagnostic challenges into four repetitive categories from family-planning, healthy pregnancy, healthy birth to Gynecology & breast health, Crystal Clear is Samsung’s comprehensive ultrasound imaging solution that provides continuous diagnostic tools designed for each stage. With one Samsung ultrasound system, clinicians can provide proper diagnosis to any Obstetrics and Gynecology patients.

Combining Intelligence and Imaging by Incorporating Decision Support Tool

• IOTA-ADNEX — In collaboration with the International Ovarian Tumor Analysis (IOTA) group, Samsung has incorporated the ADNEX (Assessment of Different NEoplasias in the adneXa) decision support tool for the classification of ovarian tumors into the ultrasound system. The ADNEX model not only accurately classifies ovarian masses as benign or malignant, but also sub-classifies malignancies giving the opportunity for more nuanced management decisions. Once the straightforward ultrasound variables have been entered into the model, ADNEX automatically gives a graphical representation of the risks of ovarian cancer to the clinician, enabling instant feedback to the patient.

At the Samsung IOTA Symposium on the 25th, Prof. Tom Bourne, from Imperial College London and a member of the steering committee of the IOTA group said, “The ADNEX model is based on data from over 5,900 women from 24 centers in ten different countries. It is a decision support tool that has both a high sensitivity and specificity for ovarian cancer, but can also sub-classify malignancies to help personalize management for patients. Integrating the model into the ultrasound machine makes it easy to use and in effect builds intelligence into the machine.”

Advanced Visualization of Fetus Anatomy

• Crystal Vue Flow — Samsung also introduced new Crystal Vue Flow, by adopting Crystal Vue which is an advanced 3D volume rendering technology and featured on the front cover of the Ultrasound in Obstetrics & Gynecology (UOG) journal in March 2016. In addition to innovative volume rendering technology, it now adds flow information that shows vascular structures with increased depth perception and demonstrates vessels in different imaging planes.

Prof. Christoph Lees, visiting Professor at KU Leuven, Belgium and Reader in Obstetrics and Fetal Medicine at Imperial College in the U.K., said, “For visualization of fetus, evaluation of fetal face and CNS, we found that Crystal Vue may provide more anatomical information the conventional 2D or 3D ultrasound can give imaging comparable to MRI,” adding, “Crystal Vue Flow combines morphological information with hemodynamic flow, and allows a deeper understanding of fetal vascular anatomical variants and neighboring vessels, particularly valuable in our experience for morbidly adherent placenta.”

With a complete package of women’s health diagnostic tools including IOTA-ADNEX and Crystal Vue Flow, Samsung will launch the WS80A with Elite containing these features from later this year.

For more information on Samsung’s global medical equipment business, please visit, www.samsungmedicalsolution.com

Samsung’s WS80A with Crystal Vue technology.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, announced that its latest imaging technology ‘Crystal Vue’ has been featured on the front cover of Ultrasound in Obstetrics & Gynecology (UOG), a renowned academic journal in the women’s healthcare industry and the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).

The March edition of the UOG featured a clinical case study by Dr. Christoph Lees, professor at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in London. Using Samsung’s premium diagnostic ultrasound system WS80A, professor Lees introduced two cases of prenatal imaging through Crystal Vue, of which the rib & vertebral images were selected as the Picture of the Month by UOG.

“Our experience with Crystal Vue over the past few months, specifically imaging of the bone and soft tissue interface, leads us to believe that it may offer new opportunities for prenatal imaging, particularly for the skeletal system, but also in facial and brain imaging,” Professor Lees stated in his study. “We were able to obtain highly detailed images that give particular information on the contour of the ribs and allow inference on mineralization.”

Crystal Vue is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus and helps easily differentiate between the soft tissue and bone. With the additional morphological information, users may deepen their understanding of the patients and fetus.

Crystal Vue was first introduced at the 25th World Congress on Ultrasound in Obstetrics and Gynecology, held in Canada in October 2015, as the latest imaging function of the WS80A. The WS80A with Crystal Vue is currently available globally.

“We are thrilled that Samsung’s latest technology was recognized in a leading academic journal as a new diagnostic imaging that can provide more clinical values in women’s health,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “With Samsung’s leading display and software technology, we will continue to develop new features that can increase diagnosis confidence and contribute to women and fetal health.”

The cover of the March issue of Ultrasound in Obstetrics & Gynecology.

To access the case study featured in the UOG, please visit,

http://onlinelibrary.wiley.com/doi/10.1002/uog.15800/full.

For detailed information on the Crystal Vue and WS80A, please visit,

http://www.samsungmedison.com/micro/WS80A_with_Elite/main.jsp.

To learn more about Samsung’s global medical equipment business, please visit,

http://www.samsung.com/global/business/healthcare/.

However, Samsung Electronics has no plan to sell Samsung Medison and there has been no such internal review for sale as the report claimed.

The report inferred the basis of the possible sale that the Head of Health & Medical Equipment Business used to take the CEO role of Samsung Medison but the CEO post has been vacant.

The President of Health & Medical Equipment Business of Samsung Electronics, Mr. Dong Soo Jun, is currently overseeing the business of Samsung Medison and expected to be an official CEO of Samsung Medison through a legitimate process at the general shareholders’ meeting and board meeting.

Samsung Electronics considers the medical equipment business one of core businesses and is committed to expanding the business with Samsung Medison.

Dong Soo Jun
President of Health & Medical Equipment Business

Samsung Medison is showcasing its latest imaging and diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology)’s 25th World Congress on Ultrasound in Obstetrics and Gynecology, being held at the Palais des congrès de Montréal in Canada from October 11 to 14. Samsung Medison, an affiliate of Samsung Electronics, is a manufacturer of diagnostic ultrasound machinery. Samsung is displaying the upgraded packages of premium ultrasound system WS80A with Elite, featuring various research functions and new visualization technology along with academic seminars on clinical values of key features.

“At this congress, the WS80A with Elite is presenting a new level of imaging and diagnostic solutions in OB/GYN, which bring users a step closer to see and diagnose the fetus with clarity and confidence,” said Soo-in Cho, CEO of Samsung Medison, adding, “Samsung continues to develop technologies that enhance user’s experience in women’s health and collaborate with professionals at the International Society of Ultrasound in Obstetrics and Gynecology for academic breakthroughs.”

The key upgrades of the WS80A with Elite include:

Semi-automated Diagnosis for Research

• 5D Heart Color — Generates nine standard fetal echocardiography views simultaneously in a single template with blood flow dynamics of fetal heart by using STIC (Spatio-Temporal Image Correlation) volume datasets.
• 5D Limb Vol. — Semi-automatically provides volume measurements of upper arm or thigh of a fetus which can be used to calculate an accurate estimation of fetal weight and nutritional status.
• 5D CNS+ — Provides axial, sagittal, and coronal views of fetal brain in nine planes by automatic measurement of biometry, following the international screening guidelines by ISUOG for fetal brain.

More Clarity in Assessing Fetus

• Crystal Vue — An advanced volume rendering technology which enables users to assess detailed information of internal and external structures of fetus by an intuitive 3D/4D visualization, providing increased diagnostic confidence.

“We have been impressed by the images we have obtained both in early pregnancy and when we have examined ovarian masses with Crystal Vue. We seem to be getting novel information,” said Professor Tom Bourne, research team leader in the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in the U.K. “We are currently carrying out clinical trials to see how this new technique impacts on diagnostic performance.”

About Samsung Medison

Samsung Medison, an affiliate of Samsung Electronics, is a global medical equipment company founded in 1985. With a mission to bring health and well-being to people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. Samsung Medison has commercialized the Live 3D technology in 2001 and since being part of Samsung Electronics in 2011, it is integrating IT, image processing, semiconductor and communication technologies into ultrasound devices for efficient and confidence diagnosis.

For more information, please visit www.samsungmedison.com.

To learn more about Samsung’s global medical equipment business, please visit samsung.com/global/business/healthcare/.